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CHAPTER 1: INTRODUCTION TO CERVICAL CANCER  
 
Each year approximately 500,000 women will be diagnosed with cervical cancer and            
274,000 will die from the disease worldwide, making it the second most common cause of               
cancer-related death in women. The staggeringly high mortality rate of the disease is largely due               1
to the fact that the disease is asymptomatic in its early stages. Precancerous lesions cause no                
symptoms at all and early stages of the disease often display unalarming symptoms: spotting              
between periods, longer and heavier periods, increased vaginal discharge, and unexplained back            
or pelvic pain. Given that a woman’s menstrual cycle and hormones are subject to fluctuations,               2
some women may not recognize these early signs as symptoms of anything at all. Risk factors                
for cervical cancer include HPV infection, age, and smoking.  3
Cervical cancer is an insidious disease―it quietly develops over years (sometimes           
decades) only rearing its head once the cancer has reached its later stages or has metastasized and                 
spread to peripheral organs. The disease begins with ​cervical dysplasia​, which is characterized             
by the growth of abnormal cells in the cervix. Precancerous cervical dysplasia is caused by the                
infection of oncogenic strains of HPV virus. From the time that abnormal cells begin to develop,                
it usually takes 10-15 years for the precancerous lesions to become malignant. This lengthy              
timeline between precancer and cancer gives medical providers a large window of time for              
intervention and prevention treatments. This time frame also allows ample opportunities for            
cervical cancer screening.  
1 Karjane, Nicole W., MD. "Pap Smear." ​Medscape​. Ed. Christine Isaacs. WebMD LLC, 02 Dec. 2016. Web. 19 Jan. 
2018. 
2 "Cervical Cancer: Symptoms and Signs." Cancer.Net. ​American Society of Clinical Oncology​, 22 Sept. 2017. Web. 
15 Jan. 2018. 
3 “Cervical Cancer: Symptoms and Signs” 
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Cervical cancer is effectively screened by use of the Papanicolaou test and the DNA test               
for HPV infection, and it is prevented using safe sex practices and the HPV vaccine. In the last                  
four decades cervical cancer incidence decreased by over 50% due to the advent of such               
screening with cervical cytology. However, the implementation of screening technology has not            4
reduced cervical cancer incidence and mortality (referred to as I&M for the remainder of this               
document) equitably as roughly 80% of cervical cancer deaths occur in developing nations. Still,              
given the resources available, screening has drastically reduced cervical cancer I&M in            
developed countries. This is well demonstrated in the U.S. as incidence from 1975-2012             
decreased from 14.8 cases per 100,00 women to only 6.5 as the Pap test became the gold                 
standard across the country. This translates to approximately 10,000 new diagnoses and 4,000             
deaths due to the disease annually.  
While the significant decrease of cervical cancer I&M in the U.S. may seem to be a                
promising accomplishment, the 4,000 deaths each year demonstrate that simply ​having screening            
and prevention technology is not enough. Theoretically, if every woman were to follow             
screening guidelines, each case of cervical dysplasia would be detected and treated before             
possibly becoming cancerous, effectively eradicating the cancer in its tracks―especially          
considering the window of 10-15 years for such detection. Eradication has become even more              
possible in recent years given the HPV test, which can predict risk, and the HPV vaccine, which                 
prevents infection and therefore cervical dysplasia and cancer. With the prevention and screening             
tools available then, cervical cancer should no longer exist―except in rare aggressive cases―in             
the resource-rich U.S. 
4 Karjane 2016 
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I argue then that it is the implementation inadequacies of such medical technologies that              
are driving the continuing rates of cervical cancer I&M in the U.S. These inadequacies are due to                 
socioeconomic barriers to access of such technologies, which disproportionately affect women           
who are low-income, immigrant, and/or people of color. I will begin with background             5
information regarding the biology of cervical cancer and elaboration of cervical dysplasia,            
screening, and prevention methods. I will then explore cervical cancer in regards to public              
health―detailing cervical cancer trends, screening programs, how to access screening, and           
federal subsidies for screening. Moving forward, I will elucidate seven significant barriers to             
access of preventative care for cervical cancer including but not limited to income, immigration              
status, and health insurance. I will then bring together the information from ​Chapters 2-4 (see               
Table of Contents) to analyze Planned Parenthood as a case study to assess the effect of                
reproductive healthcare access on cervical cancer incidence and mortality. Through these           
analyses, I will utilize ​Actor-Network Theory​, the ​Sociology of Scientific Knowledge​, and the             
Social Construction of Technology as frameworks of understanding the relationship between           
science, technology, and society. 
The goal of this body of writing is to examine the socioeconomic factors that drive the                
discrepancy between cervical cancer I&M in the U.S. and the available technologies that should              
have nearly eradicated incidence and mortality already. The critical examination of this            
discrepancy is intended to elucidate both the importance of cervical cancer screening and             
prevention methods ​and the barriers to access of such that continue to take cause preventable               
deaths. 
5 De Alba, Israel, et al. “Impact of U.S. Citizenship Status on Cancer Screening Among Immigrant Women.” 




Author’s Note: When discussing cervical cancer I&M I use the term ​women in reference to               
cisgender women with cervixes. Still, it is critical to recognize that not all women have cervixes                
and that not all people with cervixes identify as women. Gender identity will be briefly explored                
in ​Chapter 4: Barriers to Access subsection “Gender Identity.” Admittedly, one section does not              
do justice to the unique host of circumstances that bar access to reproductive healthcare for               
transgender people with cervixes who are therefore outside of the scope of this thesis. It is                
nonetheless important to validate the right to cervical cancer screening and prevention for people              
who  are not cisgender women.  
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CHAPTER 2: CERVICAL CANCER AS A DISEASE
 
Cervical Cancer: Disease Overview 
Cervical cancer is a disease in which malignant tumor cells form in the lining of the                
cervix​. The cervix is the lower region of the uterus where the organ opens into the vaginal canal.                  
It is subdivided into the upper ​endocervix and lower ​ectocervix​. The endocervix is categorized by               
the presence of glandular cells, while the ectocervix houses squamous cells. Between the two              
regions is the ​transformation zone​, wherein most cases of cervical cancer originate.   6
 
Fig. 1. Cervical anatomy of the female reproductive system. 
Nearly 90% of cervical cancers are ​squamous cell carcinomas in the ectocervix, which             
originate from the transformation zone. Most other cervical cancers are ​adenocarcinomas of the             
endocervix that originate in glandular cells. Less commonly, the cervix can be affected by              
adenosquamous carcinomas also known as ​mixed carcinomas as they are a mix of both              
squamous and glandular malignant cells. In rarer cases the cervix can also be affected by               
melanoma, lymphoma, and sarcoma. Symptoms of middle to late stage cervical cancer include             7
6 "What Is Cervical Cancer?" ​American Cancer Society​. American Cancer Society, 2018. 
7 “What Is Cervical Cancer?”  
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“spontaneous or contact bleeding” between normal menstruation, pain in the lymph nodes if             
affected, backache, and “serosanguineous foul smelling vaginal discharge.”  8
Cervical cancer itself is preceded by ​cervical dysplasia​, also known as ​cervical            
intraepithelial neoplasia (​CIN​)―abnormal, precancerous cells in the lining of the cervix.           
Cervical dysplasia is most commonly asymptomatic and therefore requires regular screening to            
be diagnosed. Although dysplasia is a necessary precursor for cervical cancer, only some women              
with the condition will later develop cancer. Cervical dysplasia is caused by a genital infection                9
of oncogenic strains of the human papillomavirus (HPV).   10
HPV is the most common sexually transmitted infection, affecting 79 million Americans            
with most sexually active people obtaining at least one strain of the virus. Over 100 strains of                 
HPV have been identified with 30 strains known to cause genital infection. In most cases the                
virus will naturally clear itself out of the body, though some persistent strains can cause genital                
warts or produce no symptoms at all. Of the strains known to cause genital infection, 13 strains                 11
have additionally been identified as high-risk for causing cervical cancer. When these strains             
infect the deepest layers of cells, the viruses damages their host cells’ DNA and induce rapid cell                 
division. An out of control increase in cell proliferation can then lead to cancer. The risk of                 12
contracting HPV can be reduced by using protection during intercourse, such as latex condoms              
or dental dams, and by being vaccinated for available strains of the virus. The Center for Disease                 
8 ​Petignat, Patrick, and Roy, Michel. "Diagnosis and Management of Cervical Cancer." BMJ : British Medical 
Journal 335.7623 (2007): 765. Print. 
9 “Cervical Dysplasia.” MedlinePlus Medical Encyclopedia, U.S. National Library of Medicine, 
medlineplus.gov/ency/article/001491.htm. 
10 Kitchener, Henry C., et al. "Developing Role of HPV in Cervical Cancer Prevention." BMJ: British Medical 
Journal 347.7921 (2013): 26. Print.  
11 “Human Papillomavirus (HPV).” Centers for Disease Control and Prevention, Centers for Disease Control and 
Prevention, 17 July 2017, www.cdc.gov/std/hpv/stdfact-hpv.htm. 
12 "HPV and Cancer." Cancer Research UK. N.p., 08 Nov. 2017. Web. 17 Nov. 2017. 
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Control (CDC) currently recommends vaccination for all children ages 11 to 12, regardless of              
gender. For women who were not vaccinated between these ages, a “catch-up” vaccination is              13
recommended between the ages of 13 and 26 as people in this age bracket exhibits higher                14
sexual activity with multiple partners, increasing the likelihood of contracting the virus. Though             
the HPV vaccine primarily aims to prevent cervical cancer, HPV infection can also cause oral,               
anal, vulvar, vaginal, and penile cancers and genital warts.  15
 
The Pap-Test 
The Papanicolaou smear―known as the Pap test―was developed in 1928 by George            
Papanicolaou and is now considered the gold standard for cervical cancer screening and             
prevention. Papanicolaou began his cytopathological research on human reproduction in 1920,           
which led him to find discernible differences under the microscope between normal and             
malignant cells taken from the vagina and cervix . These findings were revolutionary in that they                
provided a low cost, easy to perform screening procedure for cervical cancer. Widespread use              16
of the Pap test began in the 1950s and has since reduced cervical cancer I&M by at least 80%.                   17
Presently, the test has a sensitivity (rate of true positives) of 70-80% and a specificity (rate of                 
true negatives) of 95%.  18
13 “Human Papillomavirus (HPV).”  
14 Hachey, Krista J., et al. "Requiring Human Papillomavirus Vaccine for Immigrant Women." Abstract. ​Obstetrics 
& Gynecology​ 114.5 (2009): 1135-139. Web. 
15 "The HPV Vaccine: Access and Use in the U.S." The Henry J. Kaiser Family Foundation. ​The Henry J. Kaiser 
Family Foundation​, 19 Oct. 2017. Web. 
16 Tan, Siang Yong, and Yvonne Tatsumura. “George Papanicolaou (1883–1962): Discoverer of the Pap Smear.” 
Singapore Medical Journal 56.10 (2015): 586–587. PMC. Web. 17 Oct. 2017. 
17 “Cervical Cancer Screening.” National Cancer Institute, National Cancer Institute, 22 Sept. 2017, 
www.cancer.gov/types/cervical/hp/cervical-screening-pdq#link/_122_toc. 
18 “Cervical Cancer Screening.” 
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The Pap test involves exfoliating cells from the cervical transformation zone. These cells             
are obtained by inserting a speculum into the vagina and using a small tool to exfoliate the cells.                  
The sample cells are analyzed using liquid based cytology in which these cells are transferred               
from a liquid preservative in the cytology lab to a microscope slide. If cervical dysplasia is seen                 
solely from the Pap test, it is referred to as ​squamous intraepithelial lesion (SIL). ​Dysplasia that                
is diagnosed by cervical biopsy is referred to as cervical intraepithelial neoplasia (CIN).             
Subclassifications of these diagnoses are shown in the table below : 19
Types of squamous intraepithelial lesion (SIL) Types of cervical intraepithelial neoplasia (CIN) 
Low-grade (LSIL) Mild dysplasia (CIN I) 
High-grade (HSIL) Moderate to marked dysplasia (CIN II) 
Malignant Severe dysplasia to cancer in situ (CIN III) 
Atypical glandular cells (AGUS)  
Atypical squamous cells 
Table 1. Classifications of cervical dysplasia. 
Mild dysplasia (LSIL or CIN I) does not always require immediate treatment, as the              
disease may clear up on its own over time. The patient must only follow up with more frequent                  
Pap tests unless the abnormalities worsen. Moderate to severe dysplasia or chronic dysplasia is              
treated by removing the abnormal tissue by cryosurgery, laser therapy, loop electrosurgical            
excision procedure (LEEP), cone biopsy, or hysterectomy. The most common treatment           20
methods for severe or chronic dysplasia are LEEP and cryosurgery which are performed             
outpatient and have quick recovery times. For each, if abnormal cells are completely removed no               
further surgical intervention is necessary.   21
19 “Cervical Dysplasia.” 
20 “Cervical Dysplasia.” 
21 Mone, Amy. "Cervical Dysplasia Treatment." Kimmel Cancer Center. N.p., 17 July 2017. Web. 17 Nov. 2017. 
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The Pap test is an extremely powerful screening tool in that dysplasia is not only               
detected, but classified by severity before the cells become cancerous. The treatment options             
following an abnormal Pap test are immediate to treat the dysplasia, but also preventative for               
cervical cancer.  
 
Screening 
It usually takes between 10 and 15 years for the abnormal cells in cervical dysplasia to                
develop into cervical cancer. Once the disease has developed in full, the malignant cells can               22
travel to the regional lymph nodes or parametrium (the fibrous tissue that separates the vagina               
from the bladder). In order to prevent the progression of cervical dysplasia in to cervical cancer,                
the American Cancer Society recommends screening via the Pap test every three years for              
women ages 21-29 and every three to five years for women between the ages of 30 and 65.                  
Women with total hysterectomies and women over the age of 65 without any precancerous cells               
within the last 20 years of screening do not need Pap tests.  23
Screening with the Pap test is a vital health resource for women with its power to                
drastically reduce cervical cancer I&M. Cervical cancer prevention and screening are currently            
being further improved with HPV cotesting. The cobas® HPV test was FDA approved in 2014               
and is used to detect HPV 16 and HPV 18, along with ten additional high-risk HPV strains. HPV                  
testing should still be performed even if a woman has been vaccinated for the virus. While not                 
officially included in national cervical cancer guidelines, the test can nonetheless help identify             
22 “Making Sense of Cervical Cancer.” Association of Reproductive Health Professionals, Association of 
Reproductive Health Professionals, 
www.arhp.org/Publications-and-Resources/Patient-Resources/Fact-Sheets/cervical-cancer. 
23 “The American Cancer Society Guidelines for the Prevention and Early Detection of Cervical Cancer.” American 
Cancer Society, American Cancer Society, 2017. Web. 
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women at higher risk for developing cervical cancer. This test is best used in conjunction with a                 
Pap test as the same cell samples for cytology analysis can be used to detect HPV.  24
Like all screening techniques, HPV and Pap cotesting has its limitations. The            
administration of the Pap test is somewhat limited in that the tool used for specimen collection                
cannot reach the entirety of the endocervix. The cells are also assessed by individual              
cytotechnologists, which has an inherent possibility of human error. It is also necessary to              
recognize the possible psychological distress of patients who receive a false positive lab result or               
a dysplasia that will clear up on its own. Still, the greatest limitation of these screening methods                 25
is that although immediate diagnoses can be made, there is no way to differentiate whether               
abnormalities will clear themselves up or whether they will progress into cancer. This is why               




Organizations like the American Association for Cancer Research are trying to eradicate            
cervical cancer through the screening methods already available. Cervical cancer is a            
well-studied disease that is plausibly preventable, yet I&M persist. In the next chapter I will shift                
my discussion from the biology of cervical cancer to disease screening in relation to public               
health to begin to elucidate why such a preventable disease is still taking the lives of thousands                 
of American women each year. 
24 “Pap and HPV Testing.” National Cancer Institute, National Cancer Institute, 9 Sept. 2014, 
www.cancer.gov/types/cervical/pap-hpv-testing-fact-sheet#q6. 
25 “Pap and HPV Testing” 
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CHAPTER 3: CERVICAL CANCER AS A PUBLIC HEALTH CONCERN 
 
Prevention and Public Health 
As discussed in the previous chapter, the key to eradicating cervical cancer is through              
prevention with the Pap test, HPV vaccine, and HPV test. The Pap test, HPV test, and HPV                 
vaccine are available through primary care physicians, gynecologists, and reproductive health           
clinics such as Planned Parenthood. While these services are available all across the country, in               
2015 only 69% of women aged 18 and older had received a Pap test within the past three years.                   26
The inadequate implementation of Pap test is particularly concerning because as Dr. Vicki             
Benard, the Branch Chief of the Cancer Surveillance Branch in CDC’s Division of Cancer              
Prevention and Control, has stated, “regardless of the improvement in prevention methods, most             
cervical cancer occurs in women who have not had recent screening.”   27
The powers of the Pap test, HPV test, and HPV vaccine are then defined socially in their                 
implementation. Therefore their potential is innately provisional as their successes depend on            
their utilization. This can be understood by contextualizing these technologies within the STS             
framework of the ​Social Construction of Technology (SCOT). The SCOT model provides a             
foundation for understanding the complex relationship between people, society as a whole, and             
the science and technology in which the society uses. This theory suggests that human behavior               
shapes a technology while social context shapes its usage. Bruno Latour’s ​Actor Network Theory              
(ANT) further suggests that technology is not socially inanimate but rather has intrinsic             
26 "National Center for Health Statistics." Centers for Disease Control and Prevention. Centers for Disease Control 
and Prevention, 03 May 2017. Web. 24 Nov. 2017. 
27 Benard, V. B. et al. “The Effectiveness of Targeting Never or Rarely Screened Women in a National Cervical 
Cancer Screening Program for Underserved Women.”​ Cancer causes & control​ : CCC 26.5 (2015): 713–719. PMC. 
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reciprocal and changing relationships with society―technological and scientific advancements         
interact with humans as both actors comprise a complex network of relationships and             
functionalities. Using these models to conceptualize cervical cancer prevention services suggests           
that the power of these advancements depends on their social contexts. In this chapter, I will use                 
this conceptual understanding of cervical cancer preventative services and their implementation           
to assess areas of interest for public health agencies and programs. 
With the existing prevention technology already effective and available, it then becomes            
a matter of public health to address and improve its use among American women. Never or                
rarely screened women have disproportionate rates of cervical cancer I&M. These women should             
then be prioritized by outreach programs that provide access to screening methods. To address              
this, the CDC created the National Breast and Cervical Cancer Early Detection Program             
(NBCCEDP) in 1990 to provide “low-income, uninsured, and underserved women access to            
timely breast and cervical cancer screening and diagnostic services” in order to increase             
screening use. The NBCCEDP operates under the social ecological model of preventative            28
healthcare as demonstrated below: 
28 "National Breast and Cervical Cancer Early Detection Program (NBCCEDP)." Centers for Disease Control and 
Prevention. Centers for Disease Control and Prevention, 14 Sept. 2017. Web. 
14 
 
Fig. 2. The CDC’s social ecological model of preventative healthcare. Source: "Social 
Ecological Model." ​Centers for Disease Control and Prevention​. Centers for Disease 
Control and Prevention, 27 Oct. 2015. Web. 
 
This model was created to demonstrate the “myriad of factors that affect health             
outcomes” so that providers and community groups can dynamically implement effective           
activities and interventions to best serve target populations. The social ecological approach            29
practiced by the NBCCEDP reflects the importance of both treating individuals and creating             
structures to improve long-term accessibility. The NBCCEDP is currently the only national            
screening program for cervical cancer in the U.S. and provides Pap tests, HPV tests, pelvic               
exams, diagnostic testing, and referrals for treatment along with mammograms and clinical            
breast exams. This program receives of a lot clientele nationwide; from July of 2002 to June of                 
2012, ​1,485,251 women received their first Pap test via the NBCCEDP.   30
The NBCCEDP is an exemplary outreach program for under-screened women that are            
particularly at risk for developing cervical cancer. Still, it is only one program and is faced with                 
challenges of developing culturally adaptive materials, limited staff, and limited resources. As a             31
matter of public health, more programs need to be implemented to specifically target at risk               
groups and programs such as the NBCCEDP should receive more funding for the possibly              
life-saving work they do. In the U.S., ​“older women, racial minorities, and women living in rural                
areas in the South have a higher disease burden,” and should therefore be specifically provided               
with access and information about screening.   32
29 Levano, Whitney, et al. "Public Education and Targeted Outreach to Underserved Women through the National 
Breast and Cervical Cancer Early Detection Program." ​Cancer​ 120.S16 (2014): 2591-596. Web. 
30 Benard 2015 
31 Levano 2014 
32 Benard 2015 
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Public health policies and programs must also address the geographical trends in cervical             
cancer I&M. Southern rural areas are of particular concern for public health programs. There are               
higher rates of both cervical cancer I&M and women who have not been screened within the past                 
5 years in the South relative to other census regions.   33
 
Fig. 3. Cervical cancer incidence rates per 100,000 women in 2014. Source:"Gynecologic 
Cancers." ​Centers for Disease Control and Prevention​. Centers for Disease Control and 
Prevention, 07 June 2017. Web. 
 
Appalachia, southeastern Atlantic states, the lower Mississippi Valley, and areas along           
the U.S.-Mexico border display disproportionately high rates of cervical cancer I&M. Data from             
the 2000 U.S. census has indicated that in relation to non-metropolitan areas, Southern rural              
areas demonstrate higher poverty, higher unemployment rates, and lower median family           
incomes―all of which may increase risk of inadequate screening. Targeting rural areas is then              
essential as resource deprivation and low socioeconomic status have demonstrated to be            
particularly strong determinants of cervical cancer I&M. Affluent Southern communities          34
display similar rates of cervical cancer I&M to metropolitan rates which demonstrates the effects              
33 Benard, V. B., et al. “Vital signs: Cervical cancer incidence, mortality, and screening - united states, 2007-2012.”. 
Atlanta: U.S. Center for Disease Control (2014). 
34 Singh, G. K. (2012). Rural-urban trends and patterns in cervical cancer mortality, incidence, stage, and survival in 
the united states, 1950-2008. ​Journal of Community Health​, 37(1), 217-23.  
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of poverty, unemployment, and family income have on disease screening and prevention. Thus,             
Southern-rural women of low socioeconomic standing must be targeted as well as women from              
other medically underserved areas and high-risk population in metropolitan areas.  35
 
Racial-Ethnic Disparities 
Women of color are disproportionately affected by cervical cancer, demonstrating an           
apparent inverse relationship between privilege and mortality. The figure below demonstrates           36
age-adjusted cervical cancer incidence rates by ethnicity in the U.S. from 2009-2013. 
 
Fig. 4. Cervical cancer incidence per 100,000 women by ethnicity. “AIAN” represents American 
Indian/Alaska Native and “API” represents Asian/Pacific Islander. Source: "HPV and Cancer." 
Centers for Disease Control and Prevention​. Centers for Disease Control and Prevention, 03 Mar. 
2017. Web. 
Asian/Pacific Islander women and Native American/Alaskan Native women have higher          
rates of inadequate cervical cancer screening compared to other racial-ethnic groups in the U.S.              37
In fact, Vietnamese women have been the most likely group to be under-screened for cervical               
35 Singh 2012 
36Note​:  In this section, racial-ethnic qualifiers used are verbatim from their sources. Census data and other 
longitudinal reports provide options for racial-ethnic categories that may not accurately describe the way in which 
the women identify.  
37 Benard 2014 
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cancer in recent years. Black and Hispanic women also exhibit inadequate rates of screening              38
and consequently cervical cancer I&M compared to white women. However in an attempt to              
compensate for higher cervical cancer incidence rates for black and Hispanic women relative to              
white women, Asian―especially Asian immigrant―women have unfortunately been neglected         39
by general health campaigns that have otherwise helped the general population.  40
Of the major racial-ethnic groups in the U.S., Hispanic whites had the highest incidence              
rate of invasive cervical cancer from 1992-2003. In this time period, premalignant            41
adenocarcinoma was more likely to go undetected among this group than other more frequently              
screened groups. In order to address this disparity between non-Hispanic white and Hispanic             42
white women, the state of California implemented public health interventions such as telephone             
screening reminders and educational messages in Spanish, the use of female physicians and             
interpreters, and coalitions among trusted community organizations that targeted Hispanic          
women across the state. These interventions have proved successful as cervical cancer trends             43
have recently demonstrated a closing gap between non-Hispanic white and Hispanic white            
incidence. Still, as of 2014, Hispanic women were the only racial-ethnic group to have cervical               
cancer as one of the top ten causes of cancer-related deaths.  44
38 Ponce, Ninez A., et al. “Is There a Language Divide in Pap Test Use?” Medical Care, vol. 44, no. 11, 2006, pp. 
998–1004. JSTOR, JSTOR, www.jstor.org/stable/41219554. 
39 Benard 2014 
40 Ponce 2006 
41 McDougall, Jean A., et al. "Racial and Ethnic Disparities in Cervical Cancer Incidence Rates in the United States, 
1992-2003." Cancer Causes & Control 18.10 (2007): 1175-86. Print. 
42 McDougall 2007 
43 Schleicher, E. (2007). Immigrant Women and Cervical Cancer Prevention in the United States. Baltimore, MD. 
Women’s and Children’s Health Policy Center. Johns Hopkins Bloomberg School of Public Health.  
44 "United States Cancer Statistics: 1999-2014 Incidence and Mortality Web-based Report."​Centers for Disease 
Control and Prevention​. U.S. Department of Health and Human Services, 2017. Web. 14 Jan. 2018. 
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Though cervical cancer incidence rates are particularly high for both black and Hispanic             
women, death rates are nonetheless highest for black women. Among a host of detrimental,              45
systemic injustices, black women have historically been medically underserved. Current public           
health campaigns specifically aimed at increasing screening among low-income minority women           
have demonstrated progress in reducing this disparity. Since the implementation of such            
programs, the rate of cervical cancer incidence in black women with median household income              
at or below $40,000 has recently decreased.   46
There are also variations in reported barriers to access of cervical cancer screening             
among U.S. racial-ethnic groups. In March of 2016, Planned Parenthood surveyed a nationally             
and ethnically representative sample of 1,104 women at or above the age of 18 across the U.S.                 
The survey was conducted at the University of Chicago and focused on women’s experiences,              
knowledge, and beliefs regarding cervical and breast cancer screening. When asked whether they             
had ever been screened for cervical cancer, 81% of white women said yes while only 64% of                 
black and Hispanic women said yes. Black, Hispanic, and white women also differed in their               
reported barriers to access. White women had the lowest rates of citing the any of the six                 
surveyed barriers in response to questions about why they have not been adequately screened.              47
The following table conveys the rates of reported barriers to access from this study: 
45 Benard 2014 
46 Benard 2015 
47 ​Results Summary: National Survey of Women’s Knowledge of Recommended Screenings for Breast and Cervical 




Fig. 5. Perception of barriers to access among black, Hispanic, and white women. Source: ​Results Summary: 
National Survey of Women’s Knowledge of Recommended Screenings for Breast and Cervical Cancer​. Rep. Planned 
Parenthood Federation of America, 2017. Web. 
 
It is imperative that public health measures to increase cervical cancer screening focus             
especially on women of color. Outreach programs have proved to effectively reduce racial-ethnic             
disparities in cervical cancer I&M when specifically addressing these medically underserved           
populations and they should continue to do so. 
 
Mortality 
The most effective method of decreasing cervical cancer mortality is through prevention            
and early diagnosis. Data from the Surveillance, Epidemiology, and End Results Program            
(SEER) found the overall 5-year survival rate for cervical cancer patients to be 67.1% from               
2007-2013. The figure below demonstrates the continually decreasing and subsequent plateau           48
in cervical cancer I&M from 1975-2009. It is hypothesized that the rates continued to decrease               
slowly before the turn of the century as the Pap test was still spreading nationwide as a                 
preventative and diagnostic tool for cervical cancer.  





Fig. 6. Trends in 5-year relative incidence, mortality, and survival rates for cervical cancer per 
100,000 females. Source: SEER Cancer Stat Facts: Cervical Cancer. ​National Cancer Institute​. 
Bethesda, MD, http://seer.cancer.gov/statfacts/html/cervix.html 
 
The 5-year survival rate drastically decreases with high cervical cancer staging. The            
survival rates for localized, regional (cancer has spread to surrounding lymph nodes), and distant              
(cancer fully metastasized) stages are 91.5%, 57.1%, and 17.3%, respectively. Due to a lack of               49
symptoms in early stages of the disease, women who are not being regularly screened will not                
develop signs until late stages and will then have a relatively low survival rate. This               
demonstrates the importance of following screening guidelines as they offer both prevention and             
diagnosis of the disease in its early stages without persistent symptoms.  
The disparity between early and late stage survival rates demonstrate just one trend             
cervical cancer mortality. There are also marked mortality trends between age groups and             
racial-ethnic groups. Cervical cancer is most frequently diagnosed between the ages of 35 and 44               
years; 47.6% of new cases from 2010-2014 were in women between the ages of 35 and 54 years.                  
While the median age at diagnosis is 49 years, the median age at death is 58 years.   50
As for racial-ethnic groups affected, black women are most likely to die from the disease               
with 3.8 deaths per 100,000 women, while Asian/Pacific Islander women are least likely to die               
49 SEER Cancer Stat Facts: Cervical Cancer. National Cancer Institute 
50 SEER Cancer Stat Facts: Cervical Cancer. National Cancer Institute 
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with 1.7 deaths per 100,000 women. Black women unjustly bear a relatively greater burden of               51
the disease, especially compared to their white counterparts. From 2004-2009, the 5 year survival              
rate for white women was 63.5% while the survival rate from black women was markedly lower                
at 55.5%.   52
In order to reduce cervical cancer mortality, public health measures must address the             
most at-risk groups for dying of the disease. Women aged 34-55 years must be screened               
according to CDC guidelines and public health policy makers must address the systemic             
racial-ethnic disparities in mortality. Nonetheless, the foundation of decreasing mortality of           
cervical cancer is with preventative care and public health measures to increase such care.  
 
Access  
Those with health insurance or who can otherwise afford preventative healthcare for            
cervical cancer may use their primary care physician or a local Obstetrics and Gynecology              
(OB/GYN) practice for Pap tests, HPV tests, and HPV vaccines. For those who are unable to do                 
so, the most reliable options for care are Planned Parenthood (including its affiliates) and              
Federally Qualified Health Centers (FQHCs). Affiliate Planned Parenthood health centers are           
locally governed offices that operate under and are funded by the Planned Parenthood Federation              
of America. Planned Parenthood has over 650 health centers across the U.S. In 2017―the              
organization’s centennial―Planned Parenthood and its partners served 4,900,000 people.         
2,470,000 of these patients visited at least one of the 56 Planned Parenthood ​affiliated health               
centers. Additionally, Planned Parenthood served 1,500,000 clients in affiliated educational          
51 SEER Cancer Stat Facts: Cervical Cancer. National Cancer Institute 
52 Benard, V. B., et al. “Cervical cancer survival in the United States by race and stage (2001-2009): Findings from 
the CONCORD-2 study.”​ Cancer​ 123 (2017): 5119–5137.  
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programs. Of the patients who use Planned Parenthood for their reproductive and sexual             
healthcare needs, 75% have incomes at or below 150% of the federal poverty level.              53
Furthermore, Planned Parenthood offers services (including Pap tests, HPV tests, and HPV            
vaccines and treatment or referrals for cervical dysplasia and cancer) primarily to low-income             
individuals, though these services are available to people of all economic positions.  
Similarly to Planned Parenthood, FQHCs provide affordable healthcare for individuals          
with little or no other access to primary care. FQHCs are “community-based health care              
providers that receive funds from the Health Resources and Services Administration (HRSA)            
Health Center Program to provide primary care services in underserved areas.” FQHCs accept             54
Medicaid and provide care on a sliding fee scale based on ability to pay. In 2015 there were 1275                   
FQHCs across the U.S. which received nearly 97 million patient visits. Under the section 330               55
of the Public Health Service Act (PHSA), FQHCs are required to provide “voluntary family              
planning,” among their other primary care services such as mental healthcare, dentistry, and             
other preventative care.  56
53 ​By The Numbers​. Rep. Planned Parenthood Federation of America, 2017. Web. 
54 "Federally Qualified Health Centers." Health Resources & Services Administration. N.p., 01 Apr. 2017. Web. 21 
Dec. 2017 
55 "Community Health Center Delivery Sites and Patient Visits: Total CHCs, 2015." The Henry J. Kaiser Family 
Foundation. N.p., n.d. Web. 
56 Best, Alicia L, PhD,M.P.H., C.H.E.S., et al. "Examining the Influence of Cost Concern and Awareness of 
Low-Cost Health Care on Cancer Screening among the Medically  Underserved." Journal of health care for the poor 




Fig.  7. Number of FQHC locations by state. Source: "Community Health Center Delivery Sites 
and Patient Visits: Total CHCs, 2015." ​The Henry J. Kaiser Family Foundation​. N.p., n.d. Web. 
 
However, Planned Parenthood and FQHCs each face inherent limitations in providing           
care. There are nearly twice as many FQHCs than Planned Parenthood centers nationwide.             
Planned Parenthood centers are most concentrated in metropolitan areas and offer limited access             
in rural areas. The organization faces difficulties when attempting to expand in and open new               
locations in certain areas of the U.S. due to backlash against its abortion services. Its health                
centers are also often located in discreet areas for patient confidentiality and protection.             
Moreover, Planned Parenthood locations must grapple with anti-choice protests that may           
endanger the mental and physical well-being of its patients.  
FQHCs are more accessible in the U.S. than Planned Parenthood locations, though their             
services are only available to low-income Americans rather than accepting any and all patients.              
FQHCs are also frequently “the only source of mental health care, dental care, and treatment for                
patients with serious and chronic health conditions such as hypertension, cardiovascular disease,            
and diabetes,” and so most staff members are not specialized in women’s healthcare. Because              57
57 Rosenbaum, Sara. J.D. “Planned Parenthood, Community Health Centers, And Women’s Health: Getting The 
Facts Right, " Health Affairs Blog, September 2, 2015. 
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of this, there is also a larger patient population for FQHCs than Planned Parenthood which               
results in increased waiting time for appointments and limited amount of time that a patient has                
with their healthcare provider. Though there is a large presence of FQHCs across the country, the                
medically underserved are still undertreated due to lack of awareness and community outreach.             
A 2015 study of FQHC use among medically underserved populations found that over 66% of               
the participants were not aware of their local low-cost health services.  58
Planned Parenthood and FQHCs are both primary care and OB/GYN office alternatives            
with the resources to provide cervical cancer preventative care for low-income women. Within             
the public health lens, their services must be made more accessible by “increas[ing] awareness of               
available resources among medically underserved populations” in order to expand the use of Pap              
tests, HPV test, and HPV vaccine among women. Though this does not fix the more complex                59
issues that each resource faces, public awareness of their services and the importance of              
preventative care that they both offer is a necessary step in reducing cervical cancer I&M.               
Planned Parenthood and its preventative services for cervical cancer will be further elaborated             
upon in ​Chapter 5:​ ​Planned Parenthood Under Attack​. 
 
Title X 
The Title X Family Planning program was introduced in the 1970s under the Nixon              
administration as a part of the PHSA. Title X, Medicaid, and Section 330 of PHSA together are                 
the foremost sources of federal funding for more than 10,000 safety-net clinics that provide              
58 Best 2017 
59 Best 2017 
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reproductive health services to low-income individuals nationwide. The program specifically          60
supports health centers that provide contraceptive and preventative care to low-income,           
uninsured, young women of diverse racial-ethnic backgrounds. The Title X program targets            61
medically underserved individuals and communities that are often non-white; about 21% of Title             
X patients identify as black and 32% identify as Latinx.   62
In 2015 more than 4,000 clinics across the nation received Title X funding, including              
Planned Parenthood centers, FQHCs, health departments, and private non-profits specializing in           
family planning. In 2015, Title X-funded health centers provided care for 3.6 million women,              63
743,000 of whom were screened for cervical cancer ―though this figure (~20%) may seem low,              64
it is important to remember that Pap tests are recommended every 3-5 years based on patient age                 
and medical history, so not all women need to be screened annually. In short, Title X funding is                  
an important, widespread public health measure that provides reproductive and preventative           
healthcare to medically underserved women. A crucial aspect of the program is that it funds               
various organizations that serve uninsured women, such as Planned Parenthood and FQHCs;            
public health funding must be inclusive of all providers of cervical cancer screening and              
prevention services in order to combat government biases towards more controversial or lesser             
known providers.  
 
60 Ranji, Usha, et al. "Financing Family Planning Services for Low-income Women: The Role of Public Programs." 
The Henry J. Kaiser Family Foundation. N.p., 31 May 2017. Web. 
61 Fowler C, et al. Trends in Cervical Cancer Screening in Title X-Funded Health Centers — United States, 
2005–2015. MMWR Morb Mortal Wkly Rep 2017;66:981–985.  
62 Ranji 2017 
63 Ranji 2017 




This chapter discussed racial-ethnic and geographical trends in cervical cancer I&M as a             
framework for improving public health measures to increase screening. Evidently, non-white and            
Southern rural women are particularly at risk for inadequate access to preventative diagnostic             
tools and should accordingly be targeted for improvement in Pap test use. Additionally, Planned              
Parenthood and FQHCs exemplify clinical focus on providing adequate care for women            
otherwise unable to afford Pap test through primary care or OB/GYN offices. Title X supplies               
funding for clinics that offer family planning services, which cervical cancer prevention methods             
are included under. With this foundation of public health information regarding cervical cancer, I              
will specifically elaborate on significant barriers to access of preventative care of the disease in               





CHAPTER 4: BARRIERS TO ACCESS 
 
In this chapter I will analyze and discuss lower levels of income, health insurance,              
education, and health literacy, as well as immigration status, stigma, and gender identity as              
significant barriers to access of cervical cancer screening and preventative care. Each of the              
following barriers to access contributes to the prevalence of cervical cancer I&M that would              
otherwise be nearly eradicated given equal and substantial access to such care. 
 
Income 
Income is an appreciable determinant of nearly all aspects of American life, including             
women’s healthcare. On a national scale, low-income populated low-resource areas consistently           
have cervical cancer screening inadequacies. Statistically, low-income women are less likely to            65
have received a Pap test within the last three years in accordance with the CDC screening                
guidelines for cervical cancer. Due to insufficient access to screening and healthcare, women of              66
low socioeconomic status also (unfortunately) exhibit relatively higher mortality rates from the            
disease.  67
Medically underserved populations cite high cost and lack of awareness as significant            
barriers to access of healthcare even when referred to low-cost services at FQHCs.             68
65 Blumenthal, P. D., et al. “Training for Cervical Cancer Prevention Programs in Low-Resource Settings: Focus on 
Visual Inspection with Acetic Acid and Cryotherapy.” International Journal of Gynecology & Obstetrics 89: 
S30–S37(2005).Web. 
66 "Cancer Trends Progress Report." National Cancer Institute. National Cancer Institute, Jan. 2017. Web. 
67 Du, Ping, et al. "The Roles of Social Domains, Behavioral Risk, Health Care Resources, and Chlamydia in Spatial 
Clusters of US Cervical Cancer Mortality: Not all the Clusters are the Same." Cancer Causes & Control 21.10 
(2010): 1669-83. Print.  
68 Best 2017 
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Additionally, though the HPV vaccine may be readily available at little to no cost through               
programs that are designed to provide healthcare to low-income individuals such as Medicaid,             
women of low-socioeconomic standing are most likely to have limited or no knowledge             
regarding the vaccine and its relation to cervical cancer. Income unjustly dictates both a              69
woman’s access to cervical cancer prevention and her knowledge regarding critical prevention            
methods such as the HPV vaccine.  
The Alliance for Cervical Cancer Prevention (AACP) has attempted to combat the            
relatively higher risk of cervical cancer I&M among low-income women by adjusting screening             
methods to be more cost effective in low resource areas. For Pap test providers with limited                
funding such as free clinics, the AACP has recommended a focus on visual inspection methods               
that cost less than traditional Pap tests. The use of acetic acid and Lugol’s iodine for visual                 
inspection may reduce resource allocation for cervical cancer screening, yet requires special            
additional training for nurses and physicians that is a “time-consuming learning process.” This             70
is thematic of common measures to reduce long-term treatment and resource costs as this              
measure requires initial monetary investment in medical training that low resource areas may not              
have.  
Income, an evident mediating factor for cervical cancer I&M, has also displayed trends in              
cervical cancer staging upon diagnosis. Women in low-income areas are significantly more            
likely to be diagnosed with the disease once it has already metastasized, a probable explanation               
for the relatively higher mortality rates among low-income women. Moreover income trends in             71
69 Breitkopf, Carmen R., et al. "Poor Knowledge regarding the Pap Test among Low-Income Women Undergoing 
Routine Screening." Perspectives on Sexual and Reproductive Health 37.2 (2005): 78-84. Print.  
70 Blumenthal 2005; S31 
71 Mitchell, Janet B., and Lauren A. McCormack. “Time Trends in Late-Stage Diagnosis of Cervical Cancer: 
Differences by Race/Ethnicity and Income.” Medical Care 35.12 (1997): 1220–1224. 
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cervical cancer have been prevalent for decades as lower-income women have exhibited higher             
rates of disease incidence. The income disparities are powerful enough that as incidence rates              
have steadily declined among middle and high income women, low-income women have faced             
periods of simultaneous increase in incidence. From 1976-1990, high-income and middle-income           
women exhibited a 1.2% and 1.3% ​decrease (respectively) of late stage diagnosis of the disease.               
Meanwhile, during the same time period low-income women demonstrated a 2.0% ​increase in             
late stage diagnosis.  
While cervical cancer I&M have decreased drastically since the introduction of the Pap             
test, low-income women (among other disenfranchised groups) have been left behind. Income            
has prevailed as a barrier to access of preventative care for the disease even though the Pap test                  
has been proven to be effective at a relatively low price. The effects of income on health                 
insurance and Pap test use are explored further in the following section. 
 
Health Insurance 
Without universal healthcare in the U.S., whether or not one can afford health insurance              
determines the adequacy of their medical care. In the absence health insurance, a Pap test costs                
$50-200 , the full dosage of the HPV vaccine costs $390-500 , and the DNA HPV tests costs                72 73
$80-100 depending on the healthcare provider. Thus, co-testing for cervical cancer―the most            74
recommended screening method―could cost up to $300 per screening visit. Low-income           
Americans without health insurance may be unwilling or unable to afford screening and             
72 Fayed, Lisa. “How Much Does a Pap Smear Cost Without Insurance?” ​Verywell​, Verywell, June 2017, Web. 
73 Fayed, Lisa. "Does Insurance Cover HPV Vaccine Costs?" ​Verywell​. Verwell, 27 Apr. 2017. Web. 
74 Chura, Justin, MD. "FDA Approves HPV DNA Test for Cervical Cancer Screening." Cancer Treatment Centers of 
America. Cancer Treatment Centers of America, 1 May 2014. Web. 
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therefore go without adequate preventative care. This is evident by the fact that, statistically,              
uninsured or underinsured women have Pap tests and mammograms less frequently than insured             
women.  75
Approximately of 13% of adult American women are uninsured, with certain groups            
disproportionately affected by lack of insurance including black women (15%), Latina women            
(24%), and low-income women (26%). Medically underserved women are less likely to be             76
screened for cervical cancer. Between 2007-2012 11.4% of American women had not been             
screened for cervical cancer. Of these women that had not been screened, 23.1% did not have                
health insurance and 25% did not have a regular healthcare provider. Women with a continuous               77
source of healthcare through a regular provider are strikingly 55% more likely to have been               
screened for cervical cancer than women without.  78
Women without health insurance or a regular healthcare provider have limited options for             
accessing care. One way that women may access Pap tests and other cervical cancer prevention               
methods is through free clinics. There are over 1,200 free and charitable clinics in medically               
underserved areas across the U.S. that provide care to nearly 2 million people annually. Free               79
and charitable clinics differ from FQHCs because they are privately funded (through donations,             
grants, etc.) and care is provided primarily if not exclusively by volunteer medical professionals              
75 Karliner, Leah, et al. "Reducing Health Care Disparities for Minority Women in the Era of the Affordable Care 
Act: Opportunities within Primary Care." ​Journal of health care for the poor and underserved​ 27.2 (2016): 392-415. 
ProQuest. Web.  
76 Karliner 2016 
77 Benard 2014 
78 Schleicher, E. (2007). Immigrant Women and Cervical Cancer Prevention in the United States. Baltimore, MD. 
Women’s and Children’s Health Policy Center​. Johns Hopkins Bloomberg School of Public Health. 
79 "Clinics." ​NAFCC​. National Association of Free and Charitable Clinics, 2016. Web. 
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rather than employed clinic staff. These clinics offer a variety of health services including              80
women’s health. In 2016, 58% of free and charitable clinic patients were women. Though this               81
may seem to be a viable and reliable option for uninsured and underinsured women, free clinics                
do not have their own resources to provide care. Rather, they rely entirely community resources               
and donations. More troubling however is that free clinic patients report lower health-related             
qualities of life and more specifically, female free clinic patients also report lower utilization of               
Pap tests and HPV vaccination than national statistics.  82
As previously mentioned in ​Chapter 2: Cervical Cancer as a Disease​, the NBCCEDP             
provides uninsured, low-income women with preventative women’s health care. Uninsured and           
underinsured women between the ages of 21 and 64 years with income at or below 250% of the                  
federal poverty level are eligible for NBCCEDP services. 11.1% of American women qualify for              
the program, yet it only serves 6.5% of eligible women. Perhaps due to lack of awareness of the                  
program, reservations about entering it, etc. it is clearly being underutilized across the U.S. Still,               
140,073 women ​were screened for cervical cancer through the NBCCEDP in 2016. Of these              
women, 171 were diagnosed with invasive cervical cancer and 5,919 were diagnosed with             
premalignant lesions―39% of which were high grade and thus necessitated treatment via            
removal of the abnormal tissue (for methods of removal, see ​Chapter 2: Cervical Cancer as a                
Disease ​subsection “The Pap-Test”). Evidently, diagnoses of malignant cervical cancer          83
indicates a long-term lack of screening of these women as the disease takes 10-15 years to                
80 ​Comparison of Free & Charitable Clinics to Federally Funded Clinics​. Alexandria, VA: National Association of 
Free and Charitable Clinics, n.d. PDF. 
81 “Clinics” 2016 
82 Kamimura, A., et al. (2015). Women in free clinics: An assessment of health-related quality of life for prevention 
and health education. ​Journal of Community Health​, 40(4), 793-801. 
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develop once abnormal cells appear. The NBCCEDP must be made more accessible to women              
unaware of the program as it has demonstrated that medically underserved women eligible for              
the program have shown patterns of infrequent or inadequate cervical cancer screening.  
In order to reduce financial barriers to screening for uninsured and underinsured women,             
the Affordable Care Act (ACA) of 2010 required that all cancer screening be covered without               
copay for women enrolled in the insurance program and that private insurance programs must              
cover the HPV vaccine, Pap test, and HPV testing, often without cost-sharing as well. This               84
includes breast cancer genetic testing and chemoprevention for women at high risk of developing              
breast cancer, mammography screenings every 1-2 years for women over the age of 40, cervical               
cancer screening for sexually active women, and HPV tests for women aged 30 years or older                
that have had previous normal cytological Pap test results. Additionally, the ACA has             85
prohibited discontinuation of insurance coverage due to a new diagnosis or pre-existing            
condition, such as cervical dysplasia and cancer.  
A remarkable consequence of ACA provisions is that it has increased usage and full dose               
completion of the HPV vaccine. A recent study reported that 30% of surveyed unvaccinated              
adult women were unwilling to pay the approximately $390 total price for the recommended              
three doses of the vaccine but ​would choose to receive the vaccine if it were free or at a greatly                    
reduced cost. After the 2010 implementation of the ACA, coverage and prevention provisions             86
demonstrated a “significant increase in the percentage of young adult women who had initiated              
84 ​Results Summary: National Survey of Women’s Knowledge of Recommended Screenings for Breast and Cervical 
Cancer 
85 "Preventive Care Benefits for Women." ​HealthCare.gov​. U.S. Department of Health & Human Services, n.d. 
Web. 19 Dec. 2017. 
86 Lipton, B. J., & Decker, S. L. (2015). ACA provisions associated with increase in percentage of young adult 
women initiating and completing the HPV vaccine. Health Affairs, 34(5), 757-764,1-6. 
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and completed the HPV vaccine three-dose series,” suggesting that cost was notable            
barrier―even amongst insured women―to access of the prevention method. The national           87
likelihood of HPV vaccination initiation and completion increased by 7.7 and 5.8 percentage             
points, respectively, among women aged 19-25 years. This translated to approximately 854,000            
women completing the full vaccination series. These findings prove the ACA to be a positive               88
factor in decreasing socioeconomic disparity trends in cervical cancer I&M by preventing the             
spread of HPV infection among low-income women.  
The ACA has also implemented Medicaid expansion to broaden the services and            
eligibility measures for those who qualify. Adults covered by Medicaid under ACA expansion             
can receive the HPV vaccine, HPV testing, and Pap tests without cost-sharing in qualifying              
states. The Vaccines for Children (VFC) program additionally provides the HPV vaccination            
without cost for children under the age of 18 who are either eligible for Medicaid,               
uninsured/underinsured, or who identify as American Indian or Alaska Native.   89
Though the ACA and its Medicaid expansion have the ability to decrease insurance-based             
barriers to access for cervical cancer preventative care, it is nonetheless a limited and provisional               
resource for women’s healthcare. This is due to both eligibility qualifications and the tentative              
nature of the ACA under the current White House administration. Medicaid only covers ​some              
low-income individuals and families based on income and resources (Medicaid expansion           
eligibility is based solely on income). Financial qualifications for Medicaid are based on an              
individual’s relation to the federal poverty level.  
Number of Household Individuals Federal Poverty Level for 138% of Federal Poverty Level* 
87 Lipton 2015; 5 
88 Lipton 2015 
89 "The HPV Vaccine: Access and Use in the U.S." 
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Household Annual Income 
Single Individual $12,060 $16,643 
2 $16,240 $22,412 
3 $20,420 $28,180 
4 $24,600 $33,948 
5 $28,780 $39,717 
6 $32,960 $45,485 
7 $37,140 $51,254 
8 $41,320 $57,022 
Table 2. 2017 U.S. federal poverty levels for annual incomes of individuals and households. 
Source: "Federal Poverty Level (FPL)." ​HealthCare.gov​. U.S. Centers for Medicare & Medicaid 
Services, n.d. Web. 09 Jan. 2018. 
*138% of the federal poverty level is the income-based criteria for Medicaid under states with 
expanded coverage. 
As demonstrated in the table above, the federal poverty level is quite low considering the               
cost of living in the U.S. Individuals and households at or below the federal poverty level are                 
financially, socially, and medically underserved, though there are millions of economically           
disadvantaged people above that line also deserving of otherwise unaffordable healthcare. In            
short, being above the federal poverty level does not ensure the ability to afford health insurance. 
The Trump administration campaigned on the promise of repealing the ACA (often            
pejoratively referred to as “Obamacare” by Republicans that did not favor the Obama             
administration) and attempted multiple times to keep this promise within President Trump’s first             
year in office. The ACA is promising for cervical cancer eradication as it provides the necessary                
screening and prevention methods with little or no copay charges to help low-income women.              
Trump’s 2017 signing of a sweeping tax bill has already repealed the ACA’s individual mandate               
(effective in 2019) and has additionally cut subsidies, insurance enrollment periods, and certain             
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provisions from the 2010 policy. If the ACA and Medicaid expansion are to be completely               
repealed, those who depend on its provisions for cervical cancer screenings will face a              
substantial financial barrier to access of the Pap test, HPV test, and HPV vaccine. Providing               
universal health-care would ideally eliminate this barrier to access, though the possibility of such              
a program is unlikely in the U.S. currently. 
Free clinics and the NBCCEDP strive to provide considerable healthcare for low-income            
individuals, though due to funding and public health reasons are unable to equitably allot access               
to women’s health services. Those relying on the ACA and Medicaid expansion are also              
provisionally provided healthcare coverage given the political threats to repeal such policies. A             
lack of adequate health insurance prevents women unable to afford preventative services from             
receiving the care that they deserve. Without affordable women’s health services, cervical cancer             
I&M will continue to prevail among the uninsured and underinsured. 
 
Education 
In order to utilize the power of cervical cancer screening and prevention methods, one              
must first have the knowledge of how and when to use them. Though the CDC has clear                 
recommendations and guidelines for screening, the information is inadequately disseminated to           
the public. Often, the only access to this information is through primary care visits. Access to                
scientific and technological information is not egalitarian. A quintessential pillar of STS is the              
Sociology of Scientific Knowledge (SSK) theory that conceptualizes science as a social activity,             
as scientific and medical information do not exist outside of the context of society. Access and                
dissemination of knowledge is unequivocally linked to a variety of political, historical, cultural,             
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and economic factors. Thus, the promulgation of information regarding cervical cancer screening            
guidelines and treatment options define the potency of the Pap test, HPV vaccine, and HPV test.  
In the aforementioned Planned Parenthood survey (see ​Chapter 2 subsection          
“Racial-Ethnic Disparities”) 73% of respondents claimed to understand how often they must            
been screened for cervical cancer―yet only 9% were able to correctly answer that “that the               
average 21-29 year old woman should be checked every 3 years, or that the average 30-64 year                 
old woman should be checked every 3-5 years.” The overwhelming misunderstanding of            90
screening guidelines is concerning as a lack of education does not only decrease Pap test use, but                 
the ability to conceptualize what an abnormal results means and how to proceed. The lack of                
accessible knowledge of cervical cancer further results in many people not knowing that             
HPV―the most common STD in the U.S.―causes the disease. In the absence of such              
knowledge, the onus is unjustly placed upon women to encourage one another to receive Pap               
tests. Still, only 52% of surveyed women reported encouraging other women in their lives to be                
screened for cervical cancer. Women deserve to know the importance of the Pap test, HPV, and                91
co-testing in order to protect themselves from cervical cancer.  
Moreover, sexual health education in school is frequently the first formal information that             
adolescents receive regarding their reproductive anatomy and sexuality. Currently, only 24 states            
and the District of Columbia mandate sex education and only 13 states require that sex education                
be medically accurate. There are no federal or state laws that require women’s health education.               92
This is particularly troubling as knowledge about HPV and Pap testing must be disseminated              
90 ​Results Summary: National Survey of Women’s Knowledge of Recommended Screenings for Breast and Cervical 
Cancer 
91 ​Results Summary: National Survey of Women’s Knowledge of Recommended Screenings for Breast and Cervical 
Cancer 
92 "Sex and HIV Education." Guttmacher Institute. Guttmacher Institute, 02 Jan. 2018. Web. 
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earlier rather than later as younger women are at greater risk for contracting HPV than older                
women. Additionally, 37 states require that information on abstinence be required, 26 of which              93
require it be stressed as the best prevention for unplanned pregnancy and STIs.   94
A lack of comprehensive sex or sexual health education leaves adolescents unaware of             
the most effective practices for safe sex. While Pap testing is a highly effective screening tool,                
the best way to prevent cervical cancer is by not contracting HPV. Thus, students who are not                 
given information on Pap tests, HPV, and STI protection methods are at risk for cervical cancer                
later in life as they are not adequately prepared to practice safe sex, get the HPV vaccine, or                  
receive proper healthcare when they become sexually active. Studies have demonstrated a            
statistically significant positive effect on sexual risk reduction with proper sexual health            
education, particularly for socially and disadvantaged women―a phenomenon with the potential           
effect to reduce HPV transmission and consequent cervical cancer incidence.   95
When sexual health education ​is ​provided in schools it is primarily catered to             
heterosexual students. Only 12 states require discussion of sexual orientation; 9 states require it              
to be inclusive and 3 states require any discussion be negative. While the use of condoms for                 96
heterosexual intercourse is effective in preventing the spread of HPV, queer women are rarely if               
ever taught how to prevent STIs. Therefore a lack of queer education has the ability to put queer                  
women at risk for contracting HPV. HPV can be transmitted through skin-to-skin contact and is               
common among queer women―sexual transmission of HPV then likely occurs between female            
93 Breitkopf 2005  
94 “Sex and HIV Education” 
95 Shepherd, J., et al. "Cervical Cancer and Sexual Lifestyle: A Systematic Review of Health Education 
Interventions Targeted at Women." Health Education Research 15.6 (2000): 681-94. Web. 
96 “Sex and HIV Education” 
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sex partners. Plausibly due to the lack of STI prevention information for queer women, the use                97
of barrier protection such as gloves for digital sex, condoms for sex toys, and latex or plastic                 
barriers for oral-genital sex between women is infrequent. This same lack of information may              98
also contribute to the significantly lower rates of timely Pap testing among lesbian and bisexual               
women. General sexual health education is especially important for lesbian and bisexual            99
women, as many do not necessitate birth control―birth control prescriptions are the most             
common reason for OB/GYN visits where screening information is readily available.  100
Though sexual and women’s health education is most effective in preventing the spread             
of HPV and cervical cancer screening when taught at younger ages before the initiation of sexual                
activity, the information should also be provided outside of the classroom. Organizations such as              
Planned Parenthood provide educational outreach programs and accessible online information          
regarding STI protection, cervical cancer, and screening guidelines. Free clinics may as well             
provide health education programs on cervical cancer prevention. In order to inform women             
effectively, these programs should focus on perceptions of the disease, preventative           
interventions, and treatment options as well as the dissemination of factual knowledge.  101
A lack of education and knowledge regarding cervical cancer screening guidelines and            
the disease’s connection to HPV infection causes another barrier to access of cervical cancer              
prevention. Without widespread understanding of cervical cancer screening and prevention it           
97 "Special Populations." ​Centers for Disease Control and Prevention​. Centers for Disease Control and Prevention, 
25 Jan. 2017. Web. 
98 “Special Populations” 
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cannot be expected that women will receive Pap tests that meet the CDC screening guidelines.               
Therefore, in order to remove this barrier and increase Pap test use, there must be public health                 
campaigns and women’s health education to make cervical cancer knowledge more accessible. 
 
Health Literacy and Access for Non-English Speakers 
Health literacy is a “critical skill set that enables an individual to navigate the healthcare               
system,” for both native and non-native English speakers. Health literacy provides patients            102
with the capacity to comprehend basic health information and communicate within their            
healthcare systems. Having this skill is vital for knowing when to seek care, how to               
communicate with medical professionals, and most importantly, for making informed healthcare           
decisions for oneself and family. Given that the U.S. is culturally and linguistically diverse,              
health literacy and access to resources to improve these skills are necessary for non-native              
English speakers who are seeking care. As screening guidelines fluctuate and follow up             
appointments are recommended within the context of cervical cancer screening and prevention,            
health literacy has become an important component of comprehensive access to such care. It has               
therefore become a potential determinant for fundamental reproductive healthcare. 
A meta-analysis of English-language studies before May 2014 measuring health literacy           
and cervical cancer screening by Johns Hopkins School of Nursing found a “significant positive              
correlation between health literacy and Pap test receipt across ethnically diverse samples.”            103
Women with higher health literacy were found more likely to receive cervical cancer screening              
regardless of ethnicity and language abilities. This shows that those affected by a lack of health                
102 Kim, Kyounghae, et al. "Potential Links between Health Literacy and Cervical Cancer Screening  
Behaviors: A Systematic Review."​ Psycho-oncology​ 25.2 (2016): 122-30. Print. 
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literacy are not necessarily non-native English speakers, but also women without proper            
education in healthcare navigation and terminology. The study suggested that healthcare           
providers “tended to overestimate their patients’ reading levels,” leaving many inadequately           
informed on cervical cancer prevention and the meaning of abnormal test results. Women that              104
do not fully understand their test results and physician recommendations may be too embarrassed              
or linguistically unable to ask for clarifications. This lack of communication can result in              
negative adherence to screening guidelines and follow up recommendations that, within a more             
linguistically inclusive system, could save lives.  
Access to medical language and health literacy skills is necessary to improve adherence             
to screening guidelines across language barriers. It is inappropriate and neglectful for healthcare             
professionals and public health campaigns to assume a universal baseline of health literacy as it               
is impacted by both education and language proficiency levels. In order to alleviate this barrier to                
access to cervical cancer preventative care, medical professionals and community health           
organizations must understand health literacy inequalities among patient populations and tailor           
efforts for providing adequate care to varying levels of health literacy.  
A secondary data analysis of California Health Interview surveys from 2001-2003           
demonstrated that measures to improve health literacy across language barriers is an effective             
method for improving cervical cancer screening. During this time, Latinx focused public health             
campaigns targeted native Spanish speakers through providing comprehensive reproductive         
healthcare and stressing the importance of access to Spanish speaking physicians.           
Communication in one’s language of choice had a strong impact on adherence to screening              
104 Kim 2016; 126 
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guidelines: Latinas interviewed in Spanish were 1.65 times more likely to have had a Pap test                
within the last three years than those interviewed in English. This elevated adherence to              105
screening guidelines signifies the need for linguistically inclusive healthcare. Providing          
information and care in Spanish is critical in areas heavily populated by native Spanish speakers               
because 65% of Hispanics have basic or below basic health literacy, while only 28% of their                
non-Hispanic white counterparts have basic or below basic health literacy. Subsequent efforts            106
beyond the 2001-2003 health campaigns have successfully tackled the Spanish language barrier            
to reproductive healthcare access as the gap between Hispanic and white use of the Pap-test is                
continually closing.  107
However, Spanish is but one of many language barriers that affects Pap test use among               
American women. While California has increased Latinx use of the Pap-test, there is still much               
improvement to be made for women that primarily speak Mandarin, Cantonese, Korean, and             
Vietnamese. Asian immigrant populations speaking languages other than English particularly          
struggle with health literacy. The aforementioned California study found that nearly 75% of             
native Korean speakers have difficulty understanding basic medical words and about 70% of             
native Chinese have difficulty understanding both written information from their doctor and            
instructions on prescription bottles.  108
For non-native English speakers in the U.S., language barriers may cause difficulty            
communicating and existing within spaces that are linguistically exclusionary. Access to cervical            
cancer screening and preventative tools should not be determined by a woman’s English             
105 Ponce 2006 
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proficiency. In order to effectively increase adherence to cervical cancer guidelines in medically             
underserved communities, the language barrier to reproductive healthcare access must be tackled            
through efforts to increase health literacy for all women and specifically help non-native English              
speakers to communicate with their healthcare provider. Efforts must be made to increase all              
women’s health literacy as it is a foundational step towards promoting screening. Cervical cancer              
education can only be effective if women have a foundational health literacy to comprehend it. 
 
Immigration Status 
In 2010, 13% of the U.S. population was foreign born and that figure has since increased.               
In an era of marked right-wing xenophobia and racism, immigrants are often a vulnerable               109
group socioeconomically; this is true as well in the context of cervical cancer I&M. A survey by                 
the National Institutes of Health (NIH) found that between 2001-2004, only 61% of recent              
immigrants to the U.S. reported having a Pap test in the past 3 years as opposed to the 83% of                    
U.S. born women that had done so. Immigrant women are disadvantaged in their reproductive              110
healthcare access by language barriers, lack of insurance, and lack of primary, continuous             
sources of healthcare that further decrease their rates of regular Pap test use and knowledge of                
the CDC’s screening recommendations. This has resulted in disproportionate rates of I&M of             111
the disease among foreign-born American and U.S.-residing (noncitizen) women. 
Immigrants to the U.S. are often subject to lack of education, insurance, and primary              
care. As previously discussed, one’s access to health insurance is a significant determinant of              112
109 Reyes, Adriana M., and Patricia Y. Miranda. "Trends in Cancer Screening by Citizenship and Health Insurance, 
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Pap test use and reproductive healthcare as whole. Noncitizen women residing in the U.S. have               
low rates of insurance coverage even in relation to foreign-born U.S. citizens. In fact,              
foreign-born non-citizens have 25% lower coverage rates than their foreign-born citizen           
counterparts. This is likely due to income disparities between foreign-born and native-born            113
Americans as one’s income is a strong predictor of the extensiveness of health insurance              
coverage. Though immigrants have lower levels of unemployment in the U.S., their median             
weekly income is only 81.3% of the median weekly income of native-born people.             114
Additionally, non-citizen women are as a whole less likely to receive Pap tests than immigrant               
citizen women, even when data is adjusted for healthcare access, English proficiency, time lived              
in the U.S. and other sociodemographic factors.   115
As well as unequal access to health insurance, immigrant women face acculturation,            
cervical cancer knowledge, symptom awareness, the concept of preventative care, and           
culture-specific beliefs as barriers to reproductive healthcare. Aforementioned health literacy          116
is a weighty part of the acculturation process of entering the U.S. for non-native English               
speakers. For immigrants with low health literacy, access as well as adequate patient-provider             
communication can make receiving a Pap test quite challenging. Moreover, immigrant women of             
various countries of origin face their own unique barriers to access of cervical cancer              
preventative care and Pap test use. The NIH study found that lack of cervical cancer knowledge                
and symptom awareness among immigrant women has resulted in many women reporting            
absence of symptoms as a major factor for not having a regular Pap test, particularly among                
113 Reyes 2015 
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Latina and Korean immigrants; Latinas and Vietnamese women display the belief that proper             
genital hygiene negates the need for a Pap test; Latinas and Southeast Asian women exhibit               
fatalistic views of the disease and karma, respectively, as factors that undermine prevention             
strategies.  117
The cultural and citizenship specific components of immigrant barriers to access of            
preventative and diagnostic care of cervical cancer has resulted in striking disparities in I&M of               
the disease between immigrant and native-born women in the U.S. This stems from relatively              
lower rates of cervical cancer screening and consultation with healthcare providers among            
immigrant women that concerningly result in failure to detect and diagnose the disease in a               
timely manner. Cervical cancer trends among foreign-born and U.S.-born Hispanic women are            118
demonstrative of the impact that immigration has on screening and diagnosis. SEER data from              
1998-2008 found that foreign-born Hispanic women were more likely to be diagnosed with             
cervical cancer in its later stages than U.S.-born Hispanic women. This fact is further              119
substantiated by the fact that rates of cervical cancer greater than 27 per 100,000 have been                
observed among Hispanic women living in counties with higher proportions of foreign-born            
residents. Overall, non-citizen Latinx immigrants are as well less likely to attend primary care              120
visits―which are one way to access Pap tests―than the general U.S. population.  121
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Among the burdens placed upon immigrants to the U.S., cervical cancer I&M has proved              
substantial and pervasive. While the rates of cervical cancer mortality among U.S.-born women             
declined by 17% from 1985-1996, foreign-born mortality continued to increase by 22% during             
this time. A lack of access to adequate healthcare, insurance, and education has proved a lack                122
of citizenship to be a significant barrier to access of cervical cancer screening. The American               
College of Obstetrics and Gynecology has advocated for a universal healthcare package for all              
women, regardless their immigration status―a policy that would include undocumented U.S.           
residing women as well―in addition to the elimination of barriers to access of health insurance               
to prevent undue deaths due to breast and gynecological diseases such as cervical cancer. Until               123
major policy and immigrant-targeted outreach programs are adjusted to benefit the rising            
numbers of immigrants to the U.S., “citizenship will continue to add to the existing disparity               
affecting the uninsured” and further, disparity affecting cervical cancer I&M.   124
 
Stigma 
While there are various financial and external factors barring access to preventative care             
for cervical cancer, internalized biases also cause women to delay or refuse care. Stigma about               
gynecological cancers, using Medicaid, and the HPV vaccine undermine opportunities for           
cervical cancer prevention for those who otherwise have access to such measures. Firstly, there is               
an innate discomfort in discussing female reproductive health and behavior within the            
heteropatriarchal structure of American society. The female reproductive system is something           
that is not openly discussed among many women. For example, period-shaming by the media,              
122 Schleicher 2007 
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men, and even other women has led menstruating women to silence their pain and discomfort of                
PMS symptoms and hide the fact that they are menstruating at all. Reactions of disgust, surprise,                
and anger towards women talking freely about menstruation further extend to any public             
discussion of female reproductive health.  
The stigmatization of the female reproductive system and sexual behavior has the power             
to evoke aversion towards gynecological care, even when that care is cancer prevention. Survey              
research by the gynecological research charity, The Eve Appeal, has shown that 39% of women               
believe that there is a greater stigma about gynecological cancers than other cancers. There is a                125
rampant, fallacious notion that promiscuity is a cause for gynecological cancers, even though no              
associations between the two have been scientifically documented. Having multiple sexual           
partners does not increase the risk of cervical cancer―rather it is whether safe sex is practiced                
with their partners. The same survey also revealed that 34% of women believe they would be                
more comfortable discussing gynecological health issues if there was less stigma surrounding            
them.  126
As previously discussed in ​Chapter 2: Cervical Cancer as a Disease​, the CDC currently              
recommends that children receive the HPV vaccine between ages 11 and 12, presumably before              
they become sexually active. Still, the 2013 National Immunization Teen Survey indicated that             
of adolescents aged 13-17, only 37.6% of girls and 13.9% of boys had completed the three dose                 
series of the vaccine. While financial barriers to access have an influence on these low               127
numbers, it is crucial to consider the role of the parents in these scenarios. Most parents cite                 
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perceived lack of adequate research on the vaccine for delaying its administration to their              
adolescent children. Surveyed pediatricians and family practice physicians have reported          128
negative reactions of parents of adolescents upon recommendations that their children receive a             
vaccine against a sexually transmitted disease. Other hesitant parents worried that vaccinating            
their children would encourage sexual activity. While these cases are not among the majority               129
of reasons why parents refuse the vaccine, it is nonetheless important to recognize that              
sex-negative attitudes and the stigmatization of adolescent sexual activity inhibits children from            
receiving an effective prevention method against cervical cancer. It is critical that younger             
children, whose parents are more likely to refuse the vaccine for sexual reasons than older               
adolescents, receive the vaccine before initiating sexual activity because it is most effective when              
implemented before possible HPV exposure. Beginning the vaccination series at a young age in              
tandem with screening programs has been estimated to reduce cervical cancer incidence by 93%.             
While rare, aggressive cases of cervical cancer are inevitable, as the vaccination series and               130
prevention technology improve this number may further increase towards complete eradication.           
Children deserve the most effective preventative care against cervical cancer, which should not             
be impeded upon by unhealthy attitudes and stigma regarding teen sexual behavior.  
The final case of stigma discussed in this section is shame among Medicaid users. Shame               
is a significant nonfinancial barrier to all types of medical care that has been long and well                 
documented sociologically. Whether due to internalized or externalized stigma, some Medicaid           
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users cite the pathologization of poverty as a reason for delaying healthcare. A 2014 study at                
Columbia University’s School of Social Work, Providence Health & Services found that the use              
of Medicaid and its state-level programs evoked shame in those seeking care and that              
stigmatizing experiences among patients were associated with lower perceptions of quality of            
healthcare and with greater unmet medical needs.   131
Medicaid users noted that “every interaction with the healthcare system reminded them            
they could not afford care without assistance,” which has the power to shame people into               
delaying or refusing care all together. One surveyed Medicaid user claimed that “the kind of               132
insurance you have identifies you as what group you fall in...broke, poor class, the class that is                 
welfare class,” which is particularly damaging when visiting a middle-upper class doctor as it              
invokes the fear that the doctor sees the patient coming in and thinking “man, I’m paying for                 
this.” Though this stigma is an internalized fear for some, others are literally told by                133
physicians that they are wasting taxpayer dollars by seeking medical care. Some participants in              
this study were even told not to use Medicaid for preventative care, even though expanding the                
use of such care has been one of the goals of the ACA. The shame inflicted upon Medicaid users                   
is then furthered when compounded with the fact that in 2011, one-third of doctors were not                
accepting new Medicaid patients.  134
Among the participants in the revealing Columbia study, one woman exemplified the            
effect of Medicaid stigma on cervical cancer prevention in particular. The participant had             
recently qualified for the Oregon Health Plan (OHP)―an Oregon state Medicaid program            
131 Allen, Heidi, et al. “The Role of Stigma in Access to Health Care for the Poor.” ​The Milbank Quarterly​, vol. 92, 
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available to adults who earn up to 138% of the federal poverty level. She went in for a long                   135
overdue Pap test at her first primary care visit since being put on OHP. She described her                 
experience as such:  
“I felt like I was being judged for not having insurance and for not              
taking care of me…. I didn’t like how he made me feel at all. When               
I left there, I was just real sad. I was supposed to reschedule an              
appointment. But since he was rude to me, I didn’t reschedule that            
appointment.”  136
Unfortunately, following her negative experience, she did not reschedule or receive a Pap             
test. The cases reported in the study demonstrate that removing financial barriers is not enough to                
ensure equal access to healthcare and preventative medicine. American capitalism projects blame            
on those receiving government subsidies rather than the systems of inequalities that keep people              
in vulnerable economic positions. Medicaid stigma exemplifies the additional social barriers to            
preventative care for cervical cancer that remain as other barriers are negated.  
 
Gender Identity 
In the age of a powerful emergence of LGBT civil rights activism, ​all people with               
cervixes must be included in any conversations about preventative care for cervical cancer. This              
includes transgender men (transmen) and non-binary people that were assigned female at birth             
(afab). Though the preceding rhetoric of this thesis has conflated ​woman with ​having a cervix​, it                
is necessary to nonetheless recognize that all afab people are both at risk of developing cervical                
135 "Apply for OHP." Oregon Health Authority. Oregon.gov, n.d. Web. 28 Dec. 2017. 
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cancer and are deserving of preventative services. Eradication of cervical cancer is only possible              
if afab people of all genders are able to access the Pap test, HPV tests, and HPV vaccine. 
The majority of transmen do not undergo genital gender affirmation surgery until later in              
life, if at all, and will then have a cervix for a substantial part of their lives. The American                   137
College of Obstetricians and Gynecologists has therefore recommended that transmen follow the            
same cervical cancer screening guidelines as cisgender women. The CDC has also recommended             
that providers acknowledge the anatomic diversity among transmen and afab non-binary people            
as many retain a vagina and cervix, leaving them just as at risk for bacterial STDs, cervical HPV,                  
and cervical cancer as cisgender women. Consequently, anyone with a cervix, regardless of             138
gender identity, must be screened for cervical cancer.  
There is a plethora of circumstances that prevent transmen and afab non-binary people             
from receiving Pap tests that are outside the scope of this thesis, so this section will focus solely                  
on gender dysphoria and unique difficulties in Pap test analysis for non-cisgender people with              
cervixes. Gender dysphoria is a documented psychological disorder that “involves a conflict            
between a person's physical or assigned gender and the gender with which he/she/they identify.”             
Gender dysphoria can cause extreme stress for the individual with the power to completely               139
deter afab trans people from receiving cervical cancer preventative services, which are classified             
as a part of ​women’s health. Gynecologic exams and procedures have been reported by transmen               
to trigger detrimental dysphoria as they are “often a unique time when extreme emotional              
137 Peitzmeier, Sarah M., et al. "Female-to-Male Patients have High Prevalence of Unsatisfactory Paps Compared to 
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conflict between self-perceptions and physical anatomy are heightened because of physical           
touch.” In efforts to avoid gender dysphoria, transmen may avoid any kind of gynecological              140
exams and Pap tests.  
Pap tests are also uniquely challenging for transmen in that there is greater difficulty in               
obtaining adequate samples for cytological analysis. Inadequate Pap test samples cannot be            
tested due to insufficient cell counts or obstructions, such as the presence of blood, that prevent                
cytopathologists from obtaining an adequate analysis and/or diagnosis. Transmen that opt for            
hormone replacement therapy (HRT) as a part of their transition process are subject to              
gynecological side effects. Long-term use of intramuscular androgen injections induce vaginal           
atrophy that causes painful speculum insertion and epithelial atrophy that mimics cervical            
dysplasia. Testosterone use causes changes in the cervical epithelium and amenorrhea (absence            
of menstruation) that is likely to cause bleeding and obscure the sample, especially when there is                
patient/provider discomfort during the test.  141
These challenges cause transmen to be 8.3 times more likely to have an inadequate Pap               
test sample with a higher likelihood of multiple inadequate tests as well―this is particularly              
concerning due to the fact that cisgender women with inadequate Pap tests are more likely to                
develop cervical cancer and conversely, women diagnosed with cervical consequences are more            
likely to have previously had an inadequate Pap test. Though this cannot be avoided for those                142
on HRT, physicians must be aware of the distinctive biological circumstances that may impact              
results. Additionally, efforts must be made by reproductive and preventative healthcare providers            
to foster an environment that provides transmen and afab non-binary people with adequate care              
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and understanding to alleviate as much gender dysphoria as possible. Non-cisgender people with             
cervixes must also be included when discussing cervical cancer prevention and treatment            




This chapter has demonstrated the influence of income, health insurance, education,           
health literacy, immigration status, stigma, and gender identity as barriers to access of Pap tests               
and preventative care for cervical cancer (as well as reproductive healthcare as a whole). Lower               
income levels and lack of health insurance are powerful financial determinants of cervical cancer              
I&M trends, while immigration status, health literacy, stigma, and gender identity are            
demonstrative of social and group-specific trends. While these injustices must be tackled in order              
to drastically reduce if not eradicate cervical cancer in the U.S., the foundation of increasing Pap                
test use is through public and private health education. Without readily available access to CDC               
screening guidelines and knowledge regarding one’s own healthcare responsibility, women will           
continue to by systemically underscreened and further barred from access to Pap tests, HPV              
tests, and the HPV vaccine―especially women without a continuous healthcare provider to            
remind and educate them about Pap testing and pelvic exams. The aforementioned barriers to              
access in this chapter signify the critical need for adjustments in the healthcare system, education               
system, and social notions regarding women’s bodies. In the following chapter I will use Planned               
Parenthood as a case study to examine the detrimental impact of decreasing access to              









CHAPTER 5: PLANNED PARENTHOOD UNDER ATTACK 
 
Non-sexual Health Services 
Planned Parenthood and its affiliate health centers are widely known for providing STD             
testing, contraceptive care and more controversially, abortions. However, the organization offers           
a wide range of non-sexual health services including, but not limited to, general healthcare and               
screening for breast, cervical, ovarian, and testicular cancers. The CDC lists the most common              
female reproductive health concerns to be endometriosis, uterine fibroids, gynecological cancers           
(cervical, ovarian, uterine, vaginal, and vulvar), HIV/AIDS, interstitial cystitis, polycystic ovary           
syndrome, sexually transmitted diseases, and sexual violence ; Planned Parenthood is able to            143
diagnose and/or offer treatment or referrals for each of these concerns. The organization offers              
highly specific services that patients may not have other access to, such as LGBTQ health and                
sexual violence services. Planned Parenthood uniquely caters to and educates LGBTQ patients            
and even offers hormone replacement therapy for transgender patients in select areas. To combat              
sexual violence, Planned Parenthood offers immediate care, rape counseling, referrals to sexual            
assault specialists, and information regarding women’s rights, consent, and how to support a             
loved one who has been a victim of sexual or domestic violence.  
Planned Parenthood provides additional care outside of contraceptive and protective          
services. Its cancer prevention services provide over 295,000 Pap tests annually. Controversy            144
regarding the organization unfortunately fails to recognize the significant number of patients who             
receive preventative healthcare that is critical for cervical cancer treatment and eradication.  
143 "Common Reproductive Health Concerns for Women."​ Centers for Disease Control and Prevention​. Centers for 
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Threat to Planned Parenthood 
In 1976, the House of Representatives passed the Hyde Amendment which withholds            
federal Medicaid funding for abortion services―with the exception of cases of rape, incest, or              
when the mother’s life is at risk― nationwide. Most of Planned Parenthood’s federal funding is               
from Medicaid reimbursements and Title X grants which prevent the association from using any              
federal funding for abortions. Anti-choice groups and right-wing politicians have threatened to            145
“defund” Planned Parenthood, which is in actuality a misleading term. There is no federal budget               
to ​fund the organization―instead the term defunding refers to blocking funding by Medicaid and              
Title X reimbursements for patients seeking the reproductive healthcare services offered by            
Planned Parenthood. Given that approximately 60% of Planned Parenthood clients rely on this             
funding, these cuts disproportionately affect people that are low-income, living in rural areas,             
and people of color. Amidst the nationwide debate over abortion, actions have been made to               146
cut funding towards Planned Parenthood due to their offering of abortion services―even though             
only 3% of its provided services are for abortions,  none of which are federally subsidized. 147
In 2007, then congressman Mike Pence sponsored the first bill to defund Planned             
Parenthood. The bill was unsuccessful due to reproductive rights groups advocating against it.             
Though it did not pass on the national level, states like Indiana, Wisconsin, and Texas took this                 
example to defund at the state level. After subsequent efforts to defund nationally failed, in 2017                
145 "How Federal Funding Works at Planned Parenthood." ​Planned Parenthood Action Fund​. Planned Parenthood 
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Mike Pence―now vice president―made the tie-breaking vote to repeal ACA protection of            
Planned Parenthood patients receiving care by Title X funding. The ramifications of Texas’s             148
decision to cut family-planning funding that caused the closure of many Planned Parenthood and              
its affiliate clinics will be discussed in the following section, “State Defunding.” 
Movements to defund Planned Parenthood indisputably threaten the health of its patients,            
which in the case of cervical cancer screening may even result in unnecessary disease and death.                
The Congressional Budget Office (CBO) estimated in 2015 that defunding Planned Parenthood            
would result in 400,000 people losing care and 150,000-650,000 patients facing reduced access             
to care without any increase in federal revenue in return for the budget cuts. Reducing clinic                149
funding would undoubtedly limit access to contraceptive services, STI screening and treatment,            
primary care services, and cervical and breast cancer screening for low-income women.  150
In 2016, 617,677 breast and cervical cancer screenings were performed in Planned            
Parenthood clinics, of which 75,040 (12.15%) detected cancer or abnormalities in their early             
stages. Nearly 2,000 women received LEEP and cryotherapy procedures for their moderate to             151
severe cervical dysplasia ​in office at their local Planned Parenthood clinic ―others were            152
referred to external care providers for treatment. It is not uncommon for abnormalities and              
cancer diagnoses to be detected at Planned Parenthood and its affiliate centers. The organization              
prides itself on providing these possibly life-saving services; the value of which inspired five              
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women whose cancer was detected at Planned Parenthood to launch The Cancer Survivors             
Network for Planned Parenthood (CSN4PP).  
CSN4PP organizes and provides support for people who have been diagnosed with            
gynecological or breast cancer (or who have been touched by either) to stand united in support of                 
Planned Parenthood’s cancer screening services. The association launched in opposition to           
defunding threats to convey just how impactful Planned Parenthood’s cancer screenings are.            
Advocates and members of CSN4PP have shared their stories about how screening at Planned              
Parenthood saved their lives: 
Cervical Cancer survivor Gay Norman, 2015:​ “I would be dead if it hadn’t been 
for [Planned Parenthood]...There are so many women that don’t know about it 
that could use it.”  153
Cervical Cancer survivor Christy Miceli, 2017:​ “During a routine Pap smear and 
physical when I was 24, Planned Parenthood detected my cervical cancer. I was 
young and uninsured, and without a resource such as Planned Parenthood, I 
would not have been able to afford the lifesaving care I received. I would not have 
been able to afford the diagnostic testing, the various LEEP and cryotherapy 
procedures, and the extensive follow-up care….I was lucky. The early detection 
and the surgeries and procedures that followed saved my life. I did not become 
just another statistic.”  154
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Evidently, Planned Parenthood and its affiliate clinics have saved lives through early            
detection of breast and gynecological cancers, especially for black and Latinx clients who bear a               
relatively staggering burden of cervical cancer I&M nationwide. Threats to defund the            
organization put the lives of hundreds of thousands of women at risk by reducing if not                
eliminating their access to cancer prevention services. Given that 54% of Planned Parenthood             
health centers are located in areas with health professional shortage, rural areas, and/or medically              
underserved areas, the organization has proved vital in efforts to eradicate the greatly preventable              
disease of cervical cancer in the U.S. Thus, attacks on Planned Parenthood are also attacks on                
women with already substantial barriers to access to Pap tests, HPV tests, and HPV vaccines. 
 
State Defunding 
While funding efforts have not yet been cut nationally, some states have passed motions               
to defund or greatly reduce funding to Planned Parenthood locations. Though an anti-choice             
effort to reduce the rate of abortion, the state decisions to defund Planned Parenthood have had                
consequently destructive effects on other aspects of reproductive healthcare, including screening           
for cervical cancer. 
The aftermath of Texas’s efforts to defund Planned Parenthood statewide demonstrate the            
deleterious effects on cervical cancer screening that reducing women’s access to reproductive            
healthcare has caused. In 2011, Texas legislature cut state funding to family planning clinics by               
66% while redistributing the remaining grant funding away from dedicated family-planning and            
reproductive healthcare providers including Planned Parenthood. This resulted in the          155
155 Stevenson, Amanda J., et al. "Effect of Removal of Planned Parenthood from the Texas Women’​​s Health 
Program." ​New England Journal of Medicine​ 374.9 (2016): 853-60. Web. 
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subsequent closure of 82 clinics―a third of which were Planned Parenthood clinics and             
affiliates. What came next was, as two members of the Texas Policy Evaluation Project              156
reported in the Washington Post, “the network of health-care providers [fell] apart and women              
[lost] access to essential preventive services.”  157
With a decrease in reproductive healthcare supply and a stagnant demand, Texas had a              
disastrous downfall in women’s health services that resulted in a decrease in Pap tests and sharp                
increase in pregnancy-related maternal deaths. Following the mass closure of Planned           
Parenthood centers in Texas and Wisconsin (another state that made efforts to defund Planned              
Parenthood), average distance to the nearest health center increased by 100 miles. This resulted              
in a 9% decrease in Pap tests among the affected women. Meanwhile, maternal deaths in               158
Texas nearly doubled from 2011-2016―a figure rarely seen in the absence of destruction due to               
war, natural disaster, or severe economic disruption.  159
It is unlikely coincidental that Texas, a state with disproportionately limited access to             
family-planning and reproductive health centers such as Planned Parenthood, is one of the states              
with the highest rates of cervical cancer. In 2014, Texas had the 6th highest rate of cervical                 
cancer incidence and 5th highest rate of cervical cancer mortality. Still, senior Texas senator              160
John Cornyn denied the negative consequences of the defunding, rather claiming that a             
defunding of Planned Parenthood would actually ​increase access to women’s healthcare ―a           161
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statement that is blatantly ​false​. Regardless of the misinformation and anti-choice propaganda            
supporting the closure of Planned Parenthood and its affiliated clinics, the upheaval in Texas              
women’s healthcare has clearly demonstrated that defunding such clinics may result in death for              
women that rely on such services. Cervical cancer cannot be eradicated if efforts are made to                




Planned Parenthood advocates and critics of plans to defund the organization have argued             
that low-income women will not otherwise have access to reproductive healthcare and            
gynecological cancer prevention without it. In 2017, Republican leaders supported House           
Speaker Paul Ryan’s response to such criticisms by claiming that the solution lies with FQHCs.              
Anti-Planned Parenthood organizations such as the Charlotte Lozier Institute―an anti-choice           162
group known for criticizing abortions, stem cell research, and genetic research―have infamously            
released maps showing the disparity between FQHC locations and Planned Parenthood locations            
across the country. These maps have been used push the notion that defunding Planned              
Parenthood will have negligible effects on reproductive healthcare access because of the            
relatively greater number of FQHC locations available. This however is at best misleading as              
experts at the American Congress of Obstetricians and Gynecologists and the National            
Partnership for Women and Families have maintained their position that FQHCs simply ​cannot             
162 Thomson-DeVeaux, Amelia. “How Defunding Planned Parenthood Could Affect Health Care.”  ​FiveThirtyEight​, 
FiveThirtyEight, 9 Mar. 2017. Web.  
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take on all of Planned Parenthood patients. The executive director of the American Public Health               
Association has even gone so far as to describe this claim as “ludicrous.”   163
FQHCs are excellent in that they have repeatedly demonstrated efficiency on modest            
budgets, but it is unwise to assume such efficiency will be able to compensate for sudden                
closings of Planned Parenthood clinics. Due to high patient demand, not all FQHCs are able to                164
accept new patients―and those that are accepting new patients are likely to have longer wait               
times for appointments. Unfortunately, as wait times lengthen at FQHCs, care is delayed and              165
in some cases simply unavailable. Pap tests are most effectively preventative, rather than acute              166
care tools. The problem therein lies with the fact that lengthy wait times are more likely to be                  
tolerated for acute conditions rather than those for preventative care as the latter is seemingly               
nonessential to daily life. Additionally, FQHCs already struggle with high turnover of employees             
due to a shortage of healthcare workers that overloads existing staff. Moreover, federal law              167
requires that FQHCs be located in communities with few other healthcare providers.            168
Therefore, the presence of Planned Parenthood clinics deters FQHCs from being built in those              
areas. If an FQHC has not been opened in a location with a local Planned Parenthood, the closure                  
of the Planned Parenthood clinic will leave community members without a reproductive            
healthcare provider in the area.  
The previously discussed closure of Planned Parenthood locations in Texas has           
demonstrated that relying on FQHCs to provide the care otherwise offered by Planned             
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Parenthood is unambiguously ineffective. After Texas’s 2011 closure of Planned Parenthood           
clinics, FQHCs and other providers were faced with increasing women’s health service capacity             
by an average of 81% to compensate for the new influx of patients. In the immediate wake of                  
these closures, Hidalgo County alone faced a 531% increase in service demand. It is also               169
estimated that if Planned Parenthood locations were to close in Midland county, non-Planned             
Parenthood affiliated clinics would have to increase services by 537% in order to compensate for               
the decrease in women’s healthcare coverage. Considering the already limited Title X funding             170
available, low-income communities simply cannot expect other healthcare providers to be able to             
take on new patients. Resource allocation within FQHCs must account for the broad range of               
services that their patients depend on. Though Pap tests are relatively cheap, FQHCs would              
nonetheless have to expend more money, time, and space to accommodate an increased demand              
for preventative services.  
It is unwise and unjust to claim that FQHCs are an effective alternative in the wake of                 
Planned Parenthood closures. This is especially relevant as Republican efforts to repeal the             
Medicaid expansion that is covering those clinics and cut Title X spending. If cervical cancer               
I&M is to be eradicated or reduced at the very least, there must be accessible options for                 
preventative care for low-income, medically underserved women. Increasing awareness of CDC           
screening guidelines and the benefits of the HPV vaccine can only work if women can feasibly                
get such care. Therefore, clinics and programs such as Planned Parenthood that actively strive to               
provide services to the medically underserved are both essential and irreplaceable.  
 
169 Rosenbaum 2015 




Attacks on Planned Parenthood health centers and other family-planning clinics are an            
affront to women’s healthcare and the technological strides made towards cancer prevention and             
eradication. The U.S. abortion debate that has continually swept the nation ever since 1973’s ​Roe               
v. Wade supreme court ruling ensuring women access to abortion. This debate and anti-choice              
censuring of women and their healthcare providers has been a notable attack on a women’s               
bodily autonomy. As anti-choice movements persist in their disapprobation of Planned           
Parenthood, a quiet, more insidious attack on women’s bodies has been made; that being an               
attack on a woman’s right to protect herself against cancer. Given the extensive barriers to access                
of cervical cancer preventative services (see ​Chapter 4: Barriers to Access​), the closure of              
low-cost reproductive health clinics further reduces their ability to preserve if not improve their              
reproductive health. 
In an age of anti-science rhetoric, technological advances such as the Pap test, HPV test,               
and HPV vaccine are often underappreciated. The value of the Pap test is vastly unappreciated by                
those outside of the medical community. Cervical cancer was once one of the leading causes of                
cancer-related deaths of American women and as of 2014 the disease did not even make the                171
top ten. By reducing access via defunding Planned Parenthood, the technology behind the Pap              172
test is being inherently devalued―as are the lives of the women that rely on it. Any attempts to                  
reduce access to Pap tests undermine the immense efficacy of the technology. The only way to                
truly appreciate and utilize the diagnostic advancement is by expanding its use and access.  
 
171 “What is Cervical Cancer?” 




In this chapter I have used the attacks on Planned Parenthood as a case study to                
demonstrate the importance of the organization and its impact on expanding access of cervical              
cancer prevention methods, particularly to the medically underserved and underinsured. The           
battle for moralistic control over a woman’s right to choose has effectively reduced or even               
eliminated access to screening for women in affected areas. The ramifications of defunding             
independent family-planning clinics―particularly Planned Parenthood and its affiliate        
clinics―are accurately demonstrated in the aftermath of Texas’s 2011 defunding decision.           
Non-healthcare scholars or professionals have made ignorantly erroneous claims that defunding           
Planned Parenthood will have no effect on women’s health based on the presupposition that              
FQHCs can readily take on new patients. This has proven to be flagrantly incorrect and women’s                
bodies and lives have suffered as a result. As Planned Parenthood continues to be attacked by                
right-wing and anti-choice groups, the lives of women who depend on the organization for              
cancer screening are put at risk. The only way to eradicate cervical cancer in the U.S. is to                  
expand access to Pap tests, HPV tests, and HPV vaccines―a method that is undermined by the                






CHAPTER 6: CONCLUSION 
 
Women’s Health 
In a heteropatriarchal culture of regulation and politicization of women’s bodies, it is             
essential that efforts be made to protect women’s health and bodily autonomy. Outreach             
programs for cervical cancer screening and clinics that provide affordable and accessible care             
contribute to such protections by providing women with the power and choice to protect their               
bodies. All people deserve access to care aimed at preventing cancer and women especially              
deserve the right to preventative and diagnostic care for cervical cancer. This requires reducing if               
not removing barriers to access of the Pap test, HPV test, and HPV vaccine as well as improving                  
the implementation of such biotechnologies. The first step in eradicating the disease and             
enhancing women’s health nationwide is by increasing the implementation and utilization of            
screening and prevention methods for cervical cancer. 
 
Importance of Cervical Cancer Screening 
Given the slow progression cervical cancer development―10 to 15 years upon the            
formation of abnormal cells, or ​cervical dysplasia​―the disease is feasibly preventable when            
abnormal cells are detected in their early stages. Such detections can be effectively diagnosed              
with regular use of the Pap test. Theoretically, if all women were to follow CDC guidelines for                 
cervical cancer screening, abnormalities would be detected and removed if necessary before the             
cancer can develop. In recent years, screening and prevention have been made even more              
effective with the advent of the HPV test―which tests DNA for HPV-induced oncogenetic             
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changes―and the HPV vaccine. The HPV test in tandem with Pap testing (referred to as               
cotesting) not only tests for cervical abnormalities but further determines the susceptibility one             
has to those abnormalities based on whether or not the patient has been infected with high-risk                
strains of the HPV virus. The HPV vaccine is also intended to stop these strains from infecting                 
their host before any cellular damage or mutation can occur. With this vaccine and the HPV test,                 
the Pap test is then the final defense against the disease.  
Cervical cancer can develop from cervical dysplasia if it is not detected and treated              
preventatively through procedures such as LEEP, cryosurgery, cone biopsy, or hysterectomy.           
These treatment methods remove the cells before they can become malignant―screening allows            
healthcare providers to do so. Unscreened and underscreened women are at an undeniably             
greater risk of developing cervical cancer as undetected abnormal cells may quietly become             
cancerous without intervention. In order to eradicate cervical cancer in the U.S., it is these               
inadequately screened women that must be targeted through public health intervention to inform             
and reduce barriers to access of the Pap test, HPV test, and HPV vaccine. Each time a woman is                   
allowed to go unscreened or underscreened in our healthcare system, efforts to eradicate cervical              
cancer are inherently undermined. In conclusion, the only way to eradicate the disease to give               
women in the access to screening and other preventative services.  
 
The Role of Planned Parenthood in Cervical Cancer Prevention 
Planned Parenthood is a quintessential example of an effective effort to remove barriers             
to and expand access of the necessary cervical cancer preventative services for the disease’s              
eradication. For over 100 years the organization has provided affordable access to reproductive             
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health services in medically underserved areas with the intention of ensuring proper healthcare             
for ​everyone​―regardless of income, gender, orientation, etc. Nearly 75% of the organization and             
its affiliate health centers’ patients are at or below 150% of the federal poverty level (see                173
Chapter 4: Barriers to Access subsection “Health Insurance” for what defines the federal poverty              
level) and approximately 60% of patients rely on government subsidies through Medicaid and             
Title X entitlements. Approximately 12% of women that access cancer screening through            174
Planned Parenthood are found to have abnormalities. These 12% are fortunately diagnosed,            
treated, or externally referred for further analysis and treatment. Planned Parenthood’s screening            
interventions in medically underserved communities break down barriers to access such as            
income, lack of insurance, stigma, etc. to ensure reproductive healthcare to all.  
As Planned Parenthood continues to be threatened by anti-choice and right-wing efforts            
to defund the organization due to its offering of abortion services, the need for low-cost and                
accessible reproductive healthcare clinics is more evident than ever. For the hundreds of             
thousands of women that rely on Planned Parenthood for its cancer screening services, this may               
mean reduced if not eliminated access to such in the absence of the organization’s clinics. The                
NBCCEDP, FQHCs, and free and charitable clinics are nationwide alternatives for cervical            
cancer screening and prevention. However, as previously discussed, they are effectively           
incapable of undertaking patients that will lose their care in the wake of Planned Parenthood and                
its affiliate health centers’ closures. Like all organizations and programs, the NBCCEDP,            
FQHCs, and free and charitable clinics face their own issues in providing care that must not be                 
173 ​By The Numbers 
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overlooked when discussing the aftermath of defunding Planned Parenthood. Texas’s state-wide           
defunding of 82 family-planning health centers proved just that.  
Planned Parenthood is a crucial safety-net system for reproductive healthcare for those            
who currently cannot (or choose not to) use other providers and also for those who may depend                 
on their low-cost and accessible services in the future as the U.S. economy invariably fluctuates.               
The organization and its affiliates have taken strides to improve cervical cancer screening in the               
U.S. and promise to continue to do so as it fights back against defunding threats. Their affordable                 
access and continuing community education of cervical cancer prevention is an invaluable            
endeavor for cervical cancer eradication. Rather than politicizing and attacking Planned           
Parenthood, its services must be preserved to both protect women from cervical cancer and set an                
example for future associations aiming to reduce barriers to access of preventative care as well. 
 
Eradication Within Reach 
In summary, socioeconomic circumstances and inadequate access to information and          
education are driving the discrepancy between the medical and technological ability to eradicate             
cervical cancer in the U.S. and the continual prevalence of cervical cancer I&M. The war against                
cancer will continue until the disease ceases claiming the lives of so many. The trouble is though,                 
the battle against cervical cancer can be feasibly won as soon as screening and preventative               
services are made accessible to (and used by) ​everyone ​with a cervix. Approximately 4,000              
women will die each year due to lack of screening and resources to prevent and treat the disease.                  
Organizations like Planned Parenthood, community outreach programs, and publicly funded          
cancer screening services must be both protected and expanded in order save these lives. Access               
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to services and education regarding women’s bodies and the CDC’s screening guidelines must be              
widely available across the U.S. 
The sharp decline in cervical cancer I&M since the advent of the Pap test has proven the                 
power of screening and prevention methods. Though rates of cervical cancer I&M took such a               
drastic turn as the Pap test spread in its usage, it has reached a plateau in recent decades. Given                   
the efficacy of the Pap test, HPV test, and HPV vaccine, this plateau in I&M is both                 
unacceptable and avoidable​. It is now the responsibility of healthcare providers, public health             
programs, and policy makers to once again drive a decline in cervical cancer I&M by making the                 
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